Vestal Point Capital, LP ASND Holdings History
Vestal Point Capital, LP's Ascendis Pharma AS Holding Summary
As of 2025-03-31, Vestal Point Capital, LP held 150,142.00 shares of Ascendis Pharma AS(ASND), totaling $23.40 Mil. This investment constitutes 1.67% of their stock portfolio, and Vestal Point Capital, LP now holds 0.25% of the outstanding Ascendis Pharma AS(ASND) stock.
The initial trade took place in 2023Q4. And since then Vestal Point Capital, LP has made 2 purchases of ASND, at an average price of $114.61, for a total of 1.12 Mil shares. In addition, there have been 3 sales at an average price of $138.82 for 969,858.00 shares. Based on historical transaction data and ASND's current price of $173.10, Vestal Point Capital, LP's estimated gain on his ASND holdings is $32.26 Mil, reflecting a 25.13% gain to date.
Vestal Point Capital, LP ASND ($173.10) Holding Chart
Vestal Point Capital, LP ASND ($173.10) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1